Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Greenwich LifeSciences Inc shares valued at $32,760 were purchased by Patel Snehal on Apr 07 ’25. At $9.10 per share, Patel Snehal acquired 3,600 shares. The insider’s holdings grew to 5,561,602 shares worth approximately $49.78 million following the completion of this transaction.
Also, Patel Snehal purchased 5,500 shares, netting a total of over 48,015 in proceeds. Following the buying of shares at $8.73 each, the insider now holds 5,558,002 shares.
Before that, Patel Snehal had added 2,500 shares to its account. In a trade valued at $31,275, the CEO and CFO bought Greenwich LifeSciences Inc shares for $12.51 each. Upon closing the transaction, the insider’s holdings increased to 2,500 shares, worth approximately $49.69 million.
As published in their initiating research note from H.C. Wainwright on September 01, 2021, Greenwich LifeSciences Inc [GLSI] has been a Buy and the price target has been revised to $78.
Analyzing GLSI Stock Performance
During the last five days, there has been a drop of approximately -3.97%. Over the course of the year, Greenwich LifeSciences Inc shares have dropped approximately -20.30%. Shares of the company reached a 52-week high of $14.47 on 01/07/25 and a 52-week low of $8.06 on 04/07/25. A 50-day SMA is recorded $11.06, while a 200-day SMA reached $13.18.
Support And Resistance Levels for Greenwich LifeSciences Inc (GLSI)
According to the 24-hour chart, there is a support level at 8.64, which, if violated, would cause prices to drop to 8.33. In the upper region, resistance lies at 9.22. The next price resistance is at 9.50. RSI (Relative Strength Index) is 36.38 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.34, which suggests the price will decrease in the coming days. Percent R is at 68.77%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
